Zhang Yanfeng, Wang Meimei, Shao Guangcan, Shang Qingbin, Dong Mengqiu, Qin Xiaohong, Mi Li-Zhi
School of Life Sciences, Tianjin University, Tianjin 300072, China.
National Institute of Biological Sciences, Beijing 102206, China.
Acta Biochim Biophys Sin (Shanghai). 2024 Nov 29;57(3):344-355. doi: 10.3724/abbs.2024205.
Platelet-derived growth factor receptor beta (PDGFRβ), a type III receptor tyrosine kinase (RTK) with a featured kinase insert, regulates important cellular functions. Dysregulation of PDGFRβ is associated with cardiovascular and fibrosis diseases. Thus, its kinase activity needs to be precisely regulated under physiological conditions. Early studies demonstrated that its kinase is autoinhibited by its juxtamembrane segment and activated by transphosphorylation. However, additional mechanisms are required for the comprehensive regulation of the receptor kinase. Herein, we provide evidence that dimerization of activated kinases, autoinhibition by the kinase insert, and dimerization of inactive kinase, all contribute to the regulation of the receptor kinase. Moreover, we find such multiple allosteric regulation is also conserved in other type III RTKs, including colony stimulating factor 1 receptor (CSF1R). Impaired allosteric regulation of CSF1R is associated with malfunctions of microglia and demyelination of neurons in hereditary diffuse leukoencephalopathy with spheroids (HDLS).
血小板衍生生长因子受体β(PDGFRβ)是一种具有特征性激酶插入序列的III型受体酪氨酸激酶(RTK),可调节重要的细胞功能。PDGFRβ的失调与心血管疾病和纤维化疾病相关。因此,在生理条件下其激酶活性需要精确调节。早期研究表明,其激酶被近膜段自身抑制并通过转磷酸化激活。然而,受体激酶的全面调节还需要其他机制。在此,我们提供证据表明,活化激酶的二聚化、激酶插入序列的自身抑制以及非活性激酶的二聚化,均有助于受体激酶的调节。此外,我们发现这种多重变构调节在其他III型RTK中也保守存在,包括集落刺激因子1受体(CSF1R)。CSF1R变构调节受损与球形细胞遗传性弥漫性白质脑病(HDLS)中微胶质细胞功能障碍和神经元脱髓鞘有关。